Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zai Lab Limited Board/Management Information 2022

Jul 22, 2022

51136_rns_2022-07-22_c96a4089-ffb1-4e9c-8a9f-4d82da739390.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [99 x 51] intentionally omitted <==

**Zai Lab Limited 再鼎醫藥有限公司 ***

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 9688)

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

The members of the board of directors (the “ Board ”) of Zai Lab Limited (the “ Company ”) are set out below.

Director

Dr. Samantha Du (Chairperson and Chief Executive Officer)

Independent directors

Dr. Kai-Xian Chen

Dr. John Diekman (Lead Independent Director)

Ms. Nisa Leung

Mr. William Lis

Mr. Leon O. Moulder, Jr.

Mr. Peter Wirth

Mr. Scott W. Morrison Richard Gaynor, M.D.

The Board has four Board committees. The table below provides membership information of these committees on which each director of the Company serves.

Audit
Committee
Compensation
Committee
Nominating
and Corporate
Governance
Committee
Research and
Development
Committee
Dr. Samantha Du M
Dr. Kai-Xian Chen M
Dr. John Diekman M M
Ms. Nisa Leung M
Mr. William Lis M M
Mr. Leon O. Moulder,Jr. M C
Mr. Peter Wirth M C
Mr. Scott W. Morrison C
Richard Gaynor,M.D. C

Notes:

C Chairman of the relevant Board committee M Member of the relevant Board committee

July 22, 2022

* For identification only